| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
N/A |
| Shares
Out: |
26,519,000 |
| Market
Cap: |
8.38(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3545 - $0.92 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile VolitionRx is an epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop blood tests to help diagnose and monitor a range of life-altering diseases including certain cancers and diseases associated with NETosis such as sepsis and COVID-19. Co.'s tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Co. is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
269,229 |
527,979 |
1,337,263 |
1,596,263 |
| Total Buy Value |
$139,542 |
$287,917 |
$742,917 |
$924,617 |
| Total People Bought |
3 |
4 |
4 |
7 |
| Total Buy Transactions |
4 |
10 |
16 |
26 |
| Total Shares Sold |
0 |
0 |
0 |
40,000 |
| Total Sell Value |
$0 |
$0 |
$0 |
$33,000 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2025-08-17 |
2025-05-16 |
2024-11-15 |
2023-11-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Reynolds Cameron John |
President and CEO |
• • – |
2025-11-17 |
4 |
B |
$0.35 |
$7,000 |
D/D |
20,000 |
2,554,847 |
0.01 |
- |
|
| Retter Andrew |
Chief Medical Officer |
• – – |
2025-11-01 |
4 |
D |
$0.43 |
$1,991 |
D/D |
(4,588) |
146,568 |
|
- |
|
| Forterre Gael |
Chief Commercial Officer |
• – – |
2025-11-01 |
4 |
D |
$0.43 |
$761 |
D/D |
(1,753) |
153,782 |
|
- |
|
| Plummer Nicholas |
GC - Volition Diagnostics |
• – – |
2025-11-01 |
4 |
D |
$0.43 |
$2,451 |
D/D |
(5,647) |
194,084 |
|
- |
|
| Butera Salvatore Thomas |
CEO - Volition Veterinary |
• – – |
2025-11-01 |
4 |
D |
$0.43 |
$2,017 |
D/D |
(4,648) |
321,803 |
|
- |
|
| Rootsaert Rodney Gerard |
Secretary |
• – – |
2025-11-01 |
4 |
D |
$0.43 |
$1,387 |
D/D |
(3,197) |
137,258 |
|
- |
|
| Still Timothy I |
|
– • – |
2025-10-14 |
4 |
B |
$0.51 |
$24,519 |
D/D |
48,076 |
1,535,458 |
0.01 |
- |
|
| Reynolds Cameron John |
President and CEO |
• • – |
2025-10-14 |
4 |
B |
$0.51 |
$56,100 |
D/D |
110,000 |
2,534,847 |
0.01 |
- |
|
| Innes Guy Archibald |
|
– • – |
2025-10-14 |
4 |
B |
$0.51 |
$49,038 |
D/D |
96,153 |
1,062,967 |
0.01 |
- |
|
| Rootsaert Rodney Gerard |
Secretary |
• – – |
2025-10-04 |
4 |
D |
$0.65 |
$2,994 |
D/D |
(4,620) |
140,455 |
|
- |
|
| Micallef Jacob Vincent |
Chief Scientific Officer |
• – – |
2025-10-04 |
4 |
D |
$0.65 |
$3,791 |
D/D |
(5,850) |
393,089 |
|
- |
|
| Batchelor Ann-Louise |
Group Chief Marketing Officer |
• – – |
2025-10-04 |
4 |
D |
$0.65 |
$3,959 |
D/D |
(6,110) |
148,172 |
|
- |
|
| Plummer Nicholas |
GC - Volition Diagnostics |
• – – |
2025-10-04 |
4 |
D |
$0.65 |
$5,279 |
D/D |
(8,146) |
199,731 |
|
- |
|
| Forterre Gael |
Chief Commercial Officer |
• – – |
2025-10-04 |
4 |
D |
$0.65 |
$3,492 |
D/D |
(5,389) |
155,535 |
|
- |
|
| Butera Salvatore Thomas |
CEO - Volition Veterinary |
• – – |
2025-10-04 |
4 |
D |
$0.65 |
$3,780 |
D/D |
(5,834) |
326,451 |
|
- |
|
| Gaetan Michel |
Chief Operating Officer |
• – – |
2025-10-04 |
4 |
D |
$0.65 |
$7,992 |
D/D |
(12,333) |
256,746 |
|
- |
|
| Forterre Gael |
Chief Commercial Officer |
• – – |
2025-09-28 |
4 |
D |
$0.61 |
$3,329 |
D/D |
(5,503) |
160,924 |
|
- |
|
| Gaetan Michel |
Chief Operating Officer |
• – – |
2025-09-28 |
4 |
D |
$0.61 |
$6,874 |
D/D |
(11,362) |
369,079 |
|
- |
|
| Micallef Jacob Vincent |
Chief Scientific Officer |
• – – |
2025-09-28 |
4 |
D |
$0.61 |
$3,369 |
D/D |
(5,568) |
398,939 |
|
- |
|
| Butera Salvatore Thomas |
CEO - Volition Veterinary |
• – – |
2025-09-28 |
4 |
D |
$0.61 |
$3,164 |
D/D |
(5,230) |
332,285 |
|
- |
|
| Batchelor Ann-Louise |
Group Chief Marketing Officer |
• – – |
2025-09-28 |
4 |
D |
$0.61 |
$3,390 |
D/D |
(5,604) |
154,282 |
|
- |
|
| Rootsaert Rodney Gerard |
Secretary |
• – – |
2025-09-28 |
4 |
D |
$0.61 |
$2,516 |
D/D |
(4,158) |
145,075 |
|
- |
|
| Reynolds Cameron John |
President and CEO |
• • – |
2025-09-12 |
4 |
B |
$0.66 |
$9,885 |
D/D |
15,000 |
2,624,847 |
0.01 |
- |
|
| Plummer Nicholas |
GC - Volition Diagnostics |
• – – |
2025-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
24,031 |
207,877 |
|
- |
|
| Batchelor Ann-Louise |
Group Chief Marketing Officer |
• – – |
2025-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
27,400 |
159,886 |
|
- |
|
452 Records found
|
|
Page 1 of 19 |
|
|
0.02 (4.59%) 
